Even-plus Syndrome
Description
EVEN-PLUS syndrome is characterized by prenatal-onset short stature, vertebral and epiphyseal changes, microtia, midface hypoplasia with flat nose and triangular nares, cardiac malformations, and other findings including anal atresia, hypodontia, and aplasia cutis. The features overlap those reported in patients with CODAS syndrome ({600373}; Royer-Bertrand et al., 2015).
Clinical Features
Top most frequent phenotypes and symptoms related to Even-plus Syndrome
- Intellectual disability
- Global developmental delay
- Short stature
- Generalized hypotonia
- Growth delay
- Abnormal facial shape
- High palate
- Depressed nasal bridge
- Anteverted nares
- Short neck
And another 41 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Even-plus Syndrome Is also known as epiphysial-vertebral-ear dysplasia-nose-plus associated findings syndrome, epiphyseal and vertebral dysplasia, microtia, and flat nose, plus associated malformations.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Even-plus Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Comprehensive mitochondrial disorders panel.
By Centogene AG - the Rare Disease Company (Germany).
RNASEL, BCS1L, MRPL3, SARDH, SCO1, SCO2, SCP2, SDHA, SDHB, SDHC, SDHD, SLC25A12, SLC25A13, SLC25A15, SLC25A3, SLC25A4, SLC9A6, SOD2, SPG7, STAR , (...)
View the complete list with 156 more genes
Specificity
1 %
Genes
100 % |
Hereditary Sideroblastic Anemia.
By Asper Biogene Asper Biogene LLC (Estonia).
SLC19A2, PUS1, TRNT1, GLRX5, YARS2, SLC25A38, ALAS2, ABCB7, HSPA9
Specificity
12 %
Genes
100 % |
NGS Panel for Congenital and Acquired Sideroblastic Anemia.
By BLOODGENETICS BLOODGENETICS (Spain).
SF3B1, SLC19A2, PUS1, LARS2, TRNT1, GLRX5, NDUFB11, YARS2, STEAP3, SLC25A38, ALAS2, ABCB7, HSPA9
Specificity
8 %
Genes
100 % |
Nuclear-Mito NGS Panel.
By Fulgent Genetics Fulgent Genetics (United States).
RNASEL, BCS1L, RPL35A, MRPL3, RYR1, RYR2, SACS, ACSM3, SARDH, ATXN7, SCN1A, SCN1B, SCN2A, SCN4A, SCN5A, SCO1, SCO2, SCP2, SDHA, SDHB , (...)
View the complete list with 476 more genes
Specificity
1 %
Genes
100 % |
HSPA9.
By Fulgent Genetics Fulgent Genetics (United States).
HSPA9
Specificity
100 %
Genes
100 % |
You can get up to -3 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like WHITE-SUTTON SYNDROME; WHSUS PORPHYRIA, ACUTE HEPATIC